CD38 expression in B-cell chronic lymphocytic leukemia: Association with clinical presentation and outcome in 155 patients

Haematologica

Volumn 87, Issue 10, 2002, Pages 1021-1027

  Domingo Domènech, Eva ^a   Domingo Clarós, Aucia ^a   González Barca, Eva ^a   Beneitez, David ^a   Alonso, Ester ^a   Romagosa, Vicens ^a   De Sanjosé, Sílvia ^a   Petit, José ^a   Granena, Albert ^a   De Sevilla, Alberto Fernández ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

B CLL; CD38 expression; Clinical presentation; Outcome

Indexed keywords

BETA 2 MICROGLOBULIN; CD38 ANTIGEN; LACTATE DEHYDROGENASE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; CANCER MORTALITY; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT CODING; PROGNOSIS;

ADP-RIBOSYL CYCLASE; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD38; BETA 2-MICROGLOBULIN; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNOPHENOTYPING; L-LACTATE DEHYDROGENASE; LEUKEMIA, B-CELL, CHRONIC; LYMPHOCYTES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TIME FACTORS;

EID: 0036799431     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, et al. The immunological profile of Bcell disorders and proposal system for the diagnosis of CLL Leukemia 1994; 8:1640-5.
2. Moreau EJ, Matutes E, A'Hern RP, Morilla AM, Morilla RM, Owusu-Ankomah KA, et al. Improvement of the chronic lymphocytic leukemia scoring system with monoclonal antibody SN8 (CD79b). Am J Clin Pathol 1997; 108:378-82.
3. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46:219-34.
4. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, et al. A new prognostic classification of chronic lymphocytic leukemia derived from multivariate survival analysis. Cancer 1981; 48:198-206.
5. Montserrat E, Sanchez-Bisono J, Vinolas N, Rozman C. Lymphocyte doubling time in chronic lymphocytic leukaemia; analysis of its prognostic significance. Br J Haematol 1986; 62:567-75.
6. 2microglobulin is a reliable tumor marker in chronic lymphocytic leukemia. Acta Haematol 1989; 81:181-5.
7. Rozman C, Montserrat E, Rodriguez-Fernandez JM, Ayats R, Vallespi T, Parody R, et al. Bone marrow histologic pattern the best single prognostic parameter in chronic lymphocytic leukemia; a multivariate survival analysis of 329 cases. Blood 1984; 64:642-8.
8. Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ, et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 1990; 323:720-4.
9. Matutes E, Oscier D, Garcia-Marco J, Ellis J, Copplestone A, Gillingham R, et al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 1996; 92:382-8.
10. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343:1910-6.
11. Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998; 102:1515-25.
12. Naylor M, Capra JD. Mutational status of Ig VH genes provides clinically valuable information in B-cell chronic lymphocytic leukemia. Blood 1999; 94:1837-9.
13. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94:848-54.
14. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94:1840-7.
15. Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK, et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002; 99:1023-9.
16. Hamblin TJ, Orchard JA, Gardiner A, Oscier DG, Davis Z, Stevenson FK. Immunoglobulin V genes and CD38 expression in CLL. Blood 2000; 95:2455-7.
17. Ibrahim S, Keating M, Do KA, O'Brien S, Huh YO, Jilani I, et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 2001; 98:181-6.
18. Del Poeta G, Maurillo L, Venditti A, Buccisano F, Epiceno AM, Capelli G, et al. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood 2001; 98:2633-39.
19. Morabito F, Mangiola M, Stelitano C, Deaglio S, Callea V, Malavasi F. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil. Haematologica 2002; 87:217-8.
20. Oscier DG, Matutes E, Copplestone A, Pickering RM, Chapman R, Gillingham R, et al. Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12. Br J Haematol 1997; 98:934-9.